Verastem, Inc. - Common Stock - Nakit Akışı (NASDAQ:VSTM)

Financials

İşletme faaliyetlerinden elde edilen nakit -33.51 M-53.5 M-63.67 M-86.46 M-104.77 M-137.51 M -150.95 M Yatırım faaliyetlerinden elde edilen nakit -47.36 M87 K66.19 M-44.45 M59.97 M-9.62 M — Finansman faaliyetlerinden elde edilen nakit 69.63 M6.88 M51.78 M134.19 M54.78 M263.31 M 224.57 M Serbest nakit akışı -33.51 M-53.5 M-63.67 M-86.46 M-104.77 M-147.13 M -150.95 M

Verastem, Inc. - Common Stock

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

VSTM

Financials

Verastem, Inc. - Common Stock

Haberler

Verastem Oncology yönetim kuruluna Michael Bailey’i atadı

3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/22/26 - TipRanks.com

Cancer Stocks That Are Advancing the Future of Oncology Care

Verastem (VSTM) Loses 34.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Verastem, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:VSTM) 2026-05-09

BTIG, Verastem’in hisse hedefini gelir kaybı nedeniyle 18 dolara düşürdü

Verastem (VSTM) Reports Q1 Loss, Misses Revenue Estimates

Vectoring In On Verastem (NASDAQ:VSTM)

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

H.C. Wainwright, Verastem hissesi için tavsiyesini korudu

3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com

Verastem hissesi, dayanıklı deneme verileriyle BTIG’de Al tavsiyesi aldı